Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea.
Value - The contract value is withheld from publication pursuant to regulation 94(2)(b) of the Procurement Act 2023, so as not to prejudice the legitimate commercial interest of the supplier.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| GlaxoSmithKline UK Limited | 04310159 | £2 | - | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £1 initial term | GLAXOSMITHKLINE UK LIMITED | active |
Government spending data: This supplier has received £291,004,195 in 110 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care (2021-01-21 to 2026-03-12). View full payment history →